ALFA Finder| Metric | H1 FY27 | H2 FY26 | H1 FY26 |
|---|---|---|---|
| Revenue from operations | 1.1 | 1.5 | 0.3 |
| Other income | 0.0 | 0.2 | 0.0 |
| Total income | 1.1 | 1.7 | 0.3 |
| Profit before exceptional items & tax | 0.0 | 1.9 | -1.9 |
| Profit before tax | 0.0 | 1.9 | -1.9 |
| Net profit | 0.1 | 1.9 | -1.8 |
| Operating margin | 0.0% | 111.8% | -633.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -94.70% |
|---|---|
| Revenue, year on year | +266.70% |
| Operating profit, year on year | +100.00% |
| Operating profit, quarter on quarter | -100.00% |
BSE results filing, NSE: VANTA. Figures extracted from the filing.
Vanta Bioscience Ltd: key numbers
- Share price
- ₹19.89
- Market cap
- ₹14.15 Cr
- Revenue (annual)
- ₹1.82 Cr
- Net profit (annual)
- ₹0.11 Cr
- P/E (TTM)
- 130.6×Sector 36.2×
- Promoter holding
- 72.81%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vanta Bioscience Ltd
All →Vanta Bioscience Board Meeting Date
Vanta Bioscience will hold a board meeting on November 13, 2026 to consider half-year results ended September 30, 2026. The trading window stays closed until November 15, 2026.
Vanta Bioscience Other Announcement
Vanta Bioscience Ltd has filed its periodic shareholding pattern for the quarter ended September 30, 2026.
Vanta Bioscience Annual General Meeting
Vanta Bioscience Ltd has issued notice for its upcoming Annual General Meeting scheduled for September 30, 2026, to transact key business resolutions.
Vanta Bioscience Annual Report
Vanta Bioscience Ltd submitted its Annual Report and AGM notice for FY 2025-26. The 10th AGM is scheduled for September 30, 2026.
Vanta Bioscience Annual General Meeting
Vanta Bioscience approved the Annual Report for FY 2025-26 and scheduled the 10th Annual General Meeting for September 30, 2026.
Vanta Bioscience H2 FY26 Results: Turns Profitable, Net Profit ₹1.9 Cr
Vanta Bioscience Ltd reported revenue from operations of ₹1.5 Cr (+400.0% YoY) and net profit of ₹1.9 Cr for H2 FY26.
- Key figure
- Net profit ₹1.9 Cr